Development and validation of novel immune-inflammation-based clinical predictive nomograms in HER2-negative advanced gastric cancer.

Frontiers in oncology(2023)

引用 0|浏览9
暂无评分
摘要
The established nomograms integrating serum VEGFA/SII and commonly available baseline characteristics provided satisfactory performance in predicting the therapeutic efficacy and prognosis of HER2-negative AGC patients.
更多
查看译文
关键词
nomogram, predictive model, VEGFA, HER2-negative, advanced gastric cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要